This trend indicates whether your glucose may rise, go down, or stay steady. When you move the reader over the sensor, it shows up a current glucose reading and the last eight hours of data as well as a trend arrow. This is a handheld reader (as shown below) that shows your glucose readings and can store the data for up to 90 days, which gives you the chance to analyze patterns and trends. The FreeStyle Libre System has two main pieces. (two stacked quarters in the USA) The sensor lasts up to fourteen days. ![]() This is all achieved by wearing a sensor on your arm, which is the size of a two pound (UK) coin. This reduces the need for countless finger pricks and the system can indicate via a graph whether your blood sugar is rising, dropping or heading steadily. What this basically means is that the FreeStyle Libre is a system that allows you to “scan” your blood sugar using either a reader or an app on a smartphone. So, to take an official quote from the Abbot website: “The FreeStyle Libre flash glucose monitoring system is the first product in the flash glucose monitoring category and is designed to liberate people with diabetes from many of the hassles of glucose monitoring, such as routine finger pricking.” Some of you may have already heard of the FreeStyle Libre Sensor, others may not. Dexcom and Medtronic are among the other big names in the industry in the U.S.What is the FreeStyle Libre Sensor and System? In June, the med tech company got the FDA greenlight for its FreeStyle Libre 2 to be used by adults and kids over the age of 4 with diabetes.Ībbott has competition in the CGM market. At the time, the system was cleared for 10-day use, but in 2018 Abbott got another clearance for its FreestyleLibre 14 Day Flash Glucose Monitoring System. In 2017 Abbott’s Freestyle Libre system became the first CGM to be FDA cleared for use without fingerstick. The Libre Sense was designed to help athletes understand the efficacy of their nutrition choices on training and competition. Earlier this month it announced that its Libre Sense Glucose Sport Biosensor earned a CE Mark. Within the last month Abbott has had its sights set on the European market. "People living with diabetes are at the center of our design process, and we made our next-generation technology even more discreet for a better user experience to make managing diabetes as easy and seamless as possible." We've done that again with FreeStyle Libre 3, the smallest sensor that delivers life-changing benefits and best-in-class accuracy," said Jared Watkin, senior vice president for diabetes care at Abbott. "Abbott won't stop innovating when there's room to raise the bar. The company is pitching this tool as a convenient way for those living with the disease to monitor it. That number is growing, according to the agency, who attributes the uptick to obesity, unhealthy diet and physical inactivity. The company said that it will price the new product at the same price point as the last version of the device.Īccording to the World Health Organization, there are 60 million people in Europe with diabetes. While the technology is not yet available in the U.S., according to an Abbott spokesperson the company is planning to roll out the technology in other markets pending regulatory approval. Because the technology is smaller than previous versions, the company said that it is better for the environment. This new design marks the first time that the company has changed the design since launching the original FreeStyle Libre. The technology is also able to give users alerts and trends data via their smartphone app. ![]() Users apply the one-piece applicator to the back of the upper arm. This latest version is smaller than previous versions –about the size of two stacked U.S. ![]() ![]() Like its predecessor this monitor can also last for 14 days and transmit glucose data to a users’ smartphone every minute. This news comes just a few months after the company landed the much-awaited U.S. This morning Abbott announced that its continuous glucose monitor the FreeStyle Libre 3 earned a CE mark, making it cleared for use for individuals with diabetes living in the European Union.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |